Using manual HER2 FISH as a reference and both histological and cytological material of various cancer types, automated bright field HER2 assays have demonstrated comparable results suggesting that they represent reliable methods for HER2 status determination [6,7,12-14]. This evidence concerns the gene ERBB2 and cancer.